Risk factors for hospital-acquired candidemia. A matched case-control study.

Nosocomial candidemia has become an important infection not only because of an apparently increasing incidence but also because of its high fatality rate. We studied 28 risk factors through a matched case-control study that included 88 pairs of patients hospitalized between July 1983 and December 1986. The strongest single risk factor found in the univariate analysis was the number of prior antibiotics administered: the exposure odds ratio (OR) was 12.50 when patients who received three to five antibiotics were compared with those who received none to two antibiotics. A multiple logistic regression analysis using a conditional likelihood method was performed to evaluate several risk factors simultaneously. The final model selected by a stepwise procedure included the following variables: number of antibiotics received prior to infection (OR, 1.73 per unit increase), isolation of Candida species from sites other than blood (OR, 10.37), prior hemodialysis (OR, 18.13), and prior use of a Hickman catheter (OR, 7.23). It remains to be shown in controlled clinical trials whether limiting the number of antibiotics or instituting prophylaxis and/or early treatment for high-risk patients will reduce the incidence of nosocomial candidemia.

[1]  R F Woolson,et al.  Hospital-acquired candidemia. The attributable mortality and excess length of stay. , 1988, Archives of internal medicine.

[2]  C. Hill,et al.  Risk factors for candidemia in cancer patients: a case-control study , 1988, Journal of clinical microbiology.

[3]  R. Wenzel,et al.  Etiologic organisms as independent predictors of death and morbidity associated with bloodstream infections. , 1987, The Journal of infectious diseases.

[4]  R. Wenzel,et al.  Nosocomial Bloodstream Infections: Secular Trends in a Statewide Surveillance Program in Virginia , 1986, Infection Control.

[5]  W. P. Reed,et al.  Special studies of the Hickman catheter of a patient with recurrent bacteremia and candidemia. , 1986, The American journal of the medical sciences.

[6]  D. Vlahov,et al.  Candidal Suppurative Peripheral Thrombophlebitis Recognition, Prevention, and Management , 1986, Infection Control.

[7]  S. Lang,et al.  Intravascular cannula-related sepsis: two years experience. , 1985, The New Zealand medical journal.

[8]  J. Mcgowan Changing etiology of nosocomial bacteremia and fungemia and other hospital-acquired infections. , 1985, Reviews of infectious diseases.

[9]  S. Thongprasert,et al.  Systemic candidiasis in cancer patients. , 1984, The American journal of medicine.

[10]  S. Schrier,et al.  Multivariate analysis of factors associated with invasive fungal disease during remission induction therapy for acute myelogenous leukemia , 1984, Cancer.

[11]  W. Lee,et al.  Fungal infections in patients with acute leukemia. , 1982, The American journal of medicine.

[12]  C. Stratton,et al.  Candidal suppurative peripheral thrombophlebitis. , 1982, Annals of internal medicine.

[13]  P. Pockros,et al.  Parenteral nutrition complicated by candidiasis. , 1982, The Journal of infectious diseases.

[14]  D. Armstrong,et al.  Fungemia in the immunocompromised host. Changing patterns, antigenemia, high mortality. , 1981, The American journal of medicine.

[15]  J. Marini,et al.  Suppurative Candida phlebitis of a peripheral vein. , 1980, The Journal of trauma.

[16]  C. Watanakunakorn,et al.  Hospital-acquired fungemia. Its natural course and clinical significance. , 1979, The American journal of medicine.

[17]  B. Andersen,et al.  Efficacy of granulocyte transfusions in the control of systemic candidiasis in the leukopenic host. , 1978, Blood.

[18]  H. D. Rose Venous catheter-associated candidemia. , 1978, The American journal of the medical sciences.

[19]  S. Mendoza,et al.  Systemic candidiasis in infants: a case presentation and literature review. , 1977, American journal of diseases of children.

[20]  T. G. Mitchell,et al.  Recovery from disseminated candidiasis in a premature neonate. , 1974, Pediatrics.

[21]  A. Levine,et al.  Fungemia with compromised host resistance. A study of 70 cases. , 1974, Annals of internal medicine.

[22]  G. D. Vermeulen,et al.  Origin of infection in acute nonlymphocytic leukemia. Significance of hospital acquisition of potential pathogens. , 1972, Annals of internal medicine.

[23]  E. Law,et al.  Experience with systemic candidiasis in the burned patient. , 1972, The Journal of trauma.

[24]  J. Benfield,et al.  Disseminated candidiasis in surgical patients. , 1972, Surgery, gynecology & obstetrics.

[25]  W. Fletcher,et al.  Candida septicemia in the severely traumatized patient. , 1968, The Journal of trauma.

[26]  M. Seelig The role of antibiotics in the pathogenesis of Candidainfections. , 1966, The American journal of medicine.

[27]  R. Hurley Acute Disseminated (Septicaemic) Moniliasis in Adults and Children , 1964, Postgraduate medical journal.

[28]  D. Louria,et al.  Disseminated moniliasis In the Adult. , 1962 .

[29]  J. Rock,et al.  The syndrome of acute disseminated moniliasis in adults. , 1959, A.M.A. archives of internal medicine.

[30]  J. Hughes,et al.  Nosocomial infection surveillance, 1983. , 1984, MMWR. CDC surveillance summaries : Morbidity and mortality weekly report. CDC surveillance summaries.

[31]  F. Odds,et al.  Candida and candidosis , 1979 .